Christopher Causey United Therapeutics Corp (UTHR) insider trading activity

Christopher Causey is of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 4,865 shares of UTHR, which is worth approximately $1.96 Million. The most recent transaction as insider was on Aug 23, 2022, when has been sold 3,500 shares (Common Stock) at a price of $175.43 per share, resulting in proceeds of $614,005. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.87K

32.38% 3M change

16.25% 12M change

Total Value Held $1.96 Million

CHRISTOPHER CAUSEY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 23 2022	BUY Exercise of conversion of derivative security	$614,005 $175.43 p/Share	3,500 Added 35.59%	6,335 Common Stock
Jul 08 2022	BUY Exercise of conversion of derivative security	-	2,160 Added 43.24%	2,835 Common Stock
Jun 27 2022	SELL Open market or private sale	$1,183,950 $236.79 p/Share	5,000 Reduced 88.11%	675 Common Stock
Jun 27 2022	BUY Exercise of conversion of derivative security	$381,800 $76.36 p/Share	5,000 Added 46.84%	5,675 Common Stock
May 27 2022	SELL Bona fide gift	-	75 Reduced 10.0%	675 Common Stock
May 26 2022	SELL Open market or private sale	$1,124,100 $224.82 p/Share	5,000 Reduced 86.96%	750 Common Stock
May 26 2022	BUY Exercise of conversion of derivative security	$381,800 $76.36 p/Share	5,000 Added 46.51%	5,750 Common Stock
Aug 06 2021	SELL Open market or private sale	$548,100 $210.0 p/Share	2,610 Reduced 77.68%	750 Common Stock
Aug 06 2021	BUY Exercise of conversion of derivative security	$199,300 $76.36 p/Share	2,610 Added 43.72%	3,360 Common Stock
May 26 2021	SELL Bona fide gift	-	75 Reduced 9.09%	750 Common Stock
Jan 15 2021	SELL Sale (or disposition) back to the issuer	$259,230 $172.82 p/Share	1,500 Reduced 64.52%	825 Common Stock
Jan 15 2021	BUY Exercise of conversion of derivative security	$132,045 $88.03 p/Share	1,500 Added 39.22%	2,325 Common Stock
Jan 07 2021	SELL Sale (or disposition) back to the issuer	$250,575 $167.05 p/Share	1,500 Reduced 64.52%	825 Common Stock
Jan 07 2021	BUY Exercise of conversion of derivative security	$132,045 $88.03 p/Share	1,500 Added 39.22%	2,325 Common Stock
Jan 06 2021	SELL Sale (or disposition) back to the issuer	$245,265 $163.51 p/Share	1,500 Reduced 64.52%	825 Common Stock
Jan 06 2021	BUY Exercise of conversion of derivative security	$132,045 $88.03 p/Share	1,500 Added 39.22%	2,325 Common Stock
Jan 05 2021	SELL Sale (or disposition) back to the issuer	$235,155 $156.77 p/Share	1,500 Reduced 64.52%	825 Common Stock
Jan 05 2021	BUY Exercise of conversion of derivative security	$132,045 $88.03 p/Share	1,500 Added 39.22%	2,325 Common Stock
Dec 31 2020	SELL Sale (or disposition) back to the issuer	$1,138,425 $151.79 p/Share	7,500 Reduced 90.09%	825 Common Stock
Dec 31 2020	BUY Exercise of conversion of derivative security	$660,225 $88.03 p/Share	7,500 Added 47.39%	8,325 Common Stock
Dec 23 2020	SELL Sale (or disposition) back to the issuer	$224,040 $149.36 p/Share	1,500 Reduced 64.52%	825 Common Stock
Dec 23 2020	BUY Exercise of conversion of derivative security	$132,045 $88.03 p/Share	1,500 Added 39.22%	2,325 Common Stock
Oct 28 2020	SELL Sale (or disposition) back to the issuer	$264,060 $132.03 p/Share	2,000 Reduced 70.8%	825 Common Stock
Oct 28 2020	BUY Exercise of conversion of derivative security	$127,800 $63.9 p/Share	2,000 Added 41.45%	2,825 Common Stock
Oct 22 2020	SELL Sale (or disposition) back to the issuer	$305,250 $122.1 p/Share	2,500 Reduced 75.19%	825 Common Stock

Christopher Causey

Silver Spring, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Value

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR

Account